Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Exploring complementary and alternative care for multiple sclerosis

Official title: Complementary and Alternative Medicine (CAM) in Multiple Sclerosis. A Prospective Observational Study of a CAM-using Cohort

Run by Bastyr University · NCT01703429 · Data updated 2026-11-12

This study looks at how complementary and alternative medicine affects symptoms and quality of life for people with multiple sclerosis, while also tracking those who are doing particularly well to see what they might be doing differently.

More Multiple Sclerosis trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment1000 (estimated)
SponsorBastyr University
Academic / other
Locations1 site (Kenmore, Washington)
StatusRecruiting
StartedJune 2012
Main results expectedJune 2030
Study endsJune 2030
Registry record updatedFebruary 11, 2020
Trial IDNCT01703429 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18-100 diagnosed with various forms of multiple sclerosis.

Probably not a fit

Patients who are unable to read or write in English or unwilling to complete surveys may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to describe the progression of multiple sclerosis (MS) and the impact of complementary and alternative medicine (CAM) on patients' symptoms, quality of life, and lifestyle habits. It will track disease progression and adverse events while identifying individuals with the highest quality of life and least disease activity, referred to as positive deviants. These positive deviants will be compared to controls to uncover patterns in medication, diet, and lifestyle that may contribute to better outcomes in MS.

Why it matters

Potential benefit: If successful, this study could provide insights into effective complementary and alternative therapies that improve the quality of life for patients with multiple sclerosis.

How similar studies have gone: While there is ongoing interest in complementary and alternative therapies for MS, this study's specific approach to identifying positive deviants is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of multiple sclerosis (including relapsing remitting MS, secondary progressive MS, primary progressive MS, clinically isolated syndromes (CIS), radiologically-isolated syndromes (RIS), possible MS, or probable MS.
* Age 18-100

Exclusion Criteria:

* Inability to read/write in English
* Inability or unwillingness to complete surveys every six (6) months. (\~ 90 min)

Where it's running

  • Bastyr University Clinical Research Center
    Kenmore, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Laurie K Mischley, ND, PhD, MPH — Bastyr University
  • Study coordinator: Research Assistant
  • Email: neuroresearch@bastyr.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.